PharVision Advisers’s Ulta Beauty ULTA Stock Holding History

PharVision Advisers’s Portfolio ULTA Stock Details ULTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-461	Closed	-$216K	–	801
2025 Q2	$216K	Buy	+461	New	+$191K	0.31%	180

Other funds holding ULTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

PharVision Advisers's ULTA Position: Q3 2025 in Review

PharVision Advisers sold out of Ulta Beauty (ULTA) in Q3 2025, closing a stake of 461 shares — an estimated $216K sold.

PharVision Advisers first reported a position in ULTA in Q2 2025 and held it in 1 quarter. The position peaked at $216K in Q2 2025. 1,063 funds tracked by Wall St. Rank hold ULTA as of Q3 2025.

PharVision Advisers reported no remaining Ulta Beauty position as of Q3 2025 after selling out during the quarter.
PharVision Advisers sold 461 Ulta Beauty shares in Q3 2025, an estimated $216K.
PharVision Advisers first reported a position in Ulta Beauty in Q2 2025 and held it in 1 quarter.
PharVision Advisers's Ulta Beauty position peaked at $216K in Q2 2025.
1,063 funds tracked by Wall St. Rank held Ulta Beauty as of Q3 2025.

Based on PharVision Advisers's 13F filing for Q3 2025, filed 17 Nov 2025.